PharVision Advisers »

Tandem Diabetes Care shares owned by PharVision Advisers

Quarter-by-quarter ownership of Tandem Diabetes Care (TNDM) shares owned by PharVision Advisers from 13F filings

Historical chart of PharVision Advisers investment in Tandem Diabetes Care

Tip: Access up to 7 years of quarterly data

All positions including Tandem Diabetes Care held by PharVision Advisers consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Tandem Diabetes Care by PharVision Advisers

Quarter filed Position value Share count Share price at filing
2025-09-30 $270k 22k 12.14

More positions owned by PharVision Advisers

Wayfair Cl A (W)
ExlService Holdings (EXLS)
Up Fintech Hldg Sponsored Ads (TIGR)
Array Technologies Com Shs (ARRY)
Sprouts Fmrs Mkt (SFM)
Corporacion Amer Arpts S A (CAAP)
Vertiv Holdings Com Cl A (VRT)
Zevra Therapeutics Com New (ZVRA)
Bowhead Specialty Hldgs Com Shs (BOW)
Lexinfintech Hldgs Adr (LX)
Euronet Worldwide (EEFT)
Rigel Pharmaceuticals (RIGL)
Masimo Corporation (MASI)
LSB Industries (LXU)
Bright Horizons Fam Sol In D (BFAM)

View all positions for PharVision Advisers

Top funds holding Tandem Diabetes Care

BlackRock
Vanguard Group
Sessa Capital IM
UBS Group
Arrowpoint Asset Management
Jennifer Ranahan
State Street Corporation
Hood River Capital Management
Paradice Investment Management
Freestone Grove Partners
Geode Capital Management
Jacobs Levy Equity Management
Goldman Sachs Group
Jennison Associates
Morgan Stanley

View all funds holding Tandem Diabetes Care